Correlation between Serum Level of Monocyte Chemoattractant Protein-1 and Postoperative Recurrence of Spinal Tuberculosis in the Chinese Han Population

PLoS One. 2015 May 11;10(5):e0125756. doi: 10.1371/journal.pone.0125756. eCollection 2015.

Abstract

Objective: To correlate serum level of monocyte chemoattractant protein-1 (MCP-1) with postoperative recurrence of spinal tuberculosis in the Chinese Han population.

Methods: Patients of Han nationality with newly diagnosed spinal tuberculosis were consecutively included in this study. At different time points postoperatively, serum level of MCP-1 was determined using an enzyme linked immunosorbent assay. Recurrence of spinal tuberculosis after surgery and during the follow-up period was recorded. The correlation between serum MCP-1 level and recurrence of spinal tuberculosis was analyzed.

Results: A total of 169 patients with spinal tuberculosis were included in the study and followed up for an average of 2.2 ± 1.3 years (range, 1-5 years). Of these patients, 11 had postoperative recurrence of spinal tuberculosis. The patients' serum level of MCP-1 increased significantly after postoperative recurrence of spinal tuberculosis. Once the symptoms of recurrence were cured, the serum level of MCP-1 decreased significantly and it did not differ from patients without disease recurrence.

Conclusion: Postoperative recurrence of spinal tuberculosis is likely to increase the serum level of MCP-1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Chemokine CCL2 / blood*
  • Child
  • Child, Preschool
  • China
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Postoperative Period
  • Recurrence
  • Tomography, X-Ray Computed
  • Tuberculosis, Spinal / blood*
  • Tuberculosis, Spinal / diagnosis
  • Tuberculosis, Spinal / microbiology*
  • Tuberculosis, Spinal / surgery
  • Young Adult

Substances

  • Chemokine CCL2

Grants and funding

The study was supported by The National Natural Science Fund, No. 81401818 and No. 81301576, China.